Leading Edge Financial Planning LLC Johnson & Johnson Transaction History

Leading Edge Financial Planning LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	BUY	$155.75 - $174.48 $1,090 - $1,221	7 Added 0.48%	1,454 $226 Million
Q2 2023 Jul 17, 2023	SELL	$154.35 - $166.11 $17,904 - $19,268	-116 Reduced 7.42%	1,447 $239 Million
Q1 2023 Apr 20, 2023	BUY	$151.05 - $180.26 $1,510 - $1,802	10 Added 0.64%	1,563 $242 Million
Q4 2022 Mar 02, 2023	BUY	$160.2 - $179.79 $248,790 - $279,213	1,553 New	1,553 $274 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Leading Edge Financial Planning LLC, based on Form 13F filings with the SEC.

Stay updated on Leading Edge Financial Planning LLC with notifications on news.